NCT02636023View on ClinicalTrials.gov

Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Cardiovascular Risk Factor

Interventions

DEVICE

SPhENo-Cardiograph

Trial Locations (1)

V3L 5N8

Boucher Institute of Naturopathic Medicine, New Westminster

All Listed Sponsors

lead

Heart Force Medical Inc.

INDUSTRY

NCT02636023 - Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI) | Biotech Hunter | Biotech Hunter